Shardul Kulkarni of Angel Broking is of the view that Sun Pharmaceutical Industries may fall to Rs 440. "Going forward we will see further decline in case of Sun Pharma. The stock has already given a breakdown, has now moved into a lower top, lower bottom cycle on the daily chart," he adds.
first published: Aug 21, 2013 05:40 pm
A collection of the most-viewed Moneycontrol videos.
Wall Street Gains For 2nd Day Post Nvidia's Earnings Beat; Will Bulls Reclaim 25,600 On Expiry Day?
What Is Claude Code Security? The Anthropic AI Tool That Spooked Cybersecurity Stocks | 4K
Nifty, Sensex Trim Gains; Metals & IT Top Gainers But PSU Banks See Profit Booking | Closing Bell Live
India AI Summit: Vilas Dhar on Policy, Jobs, Data Centers & the Road Ahead | Political Economy
